title: Interaction between insulin and estradiol in regulation of cardiac glucose and free fatty acid transporters.
abstract: The estrogen binding to specific extranuclear receptors (ER) activates several intracellular pathways that are activated by insulin as well. Moreover, insulin and estradiol (E2) influence cardiac energy substrates, blood glucose and free fatty acids (FFAs), and both hormones exert cardio-beneficial effects. In view of these facts, we suggest that cross-talk between their signaling pathways might have an important role in regulation of cardiac energy substrate transport. Ovariectomized rats were treated with insulin, estradiol (E2), or their combination 20, 30, or 40 min before analysis of blood glucose and FFA level, as well as cardiac plasma membranes (PM) and low density microsomes (LDM) content of glucose (GLUT4 and GLUT1) and FFA (CD36) transporters. Insulin, given alone, or in combination with E2, decreased plasma glucose level at all time points, but did not influence FFA level, while E2 treatment itself did not change glucose and FFA concentration. Insulin increased PM GLUT4 and GLUT1 content 30 and 40 min after treatment and the increases were partially accompanied by decrease in transporter LDM content. E2 increased PM content and decreased LDM content only of GLUT4 at 30 min. Insulin generally, and E2 at 20 min increased CD36 content in PM fraction. Both hormones decreased CD36 LDM content 20 min after administration. Effect of combined treatment mostly did not differ from single hormone treatment, but occasionally, particularly in distribution of GLUT4, combined treatment emphasized single hormone effect, suggesting that insulin and E2 act synergistically in regulation of energy substrate transporters in cardiac tissue.
authors.affiliation: Laboratory for Molecular Biology and Endocrinology, Vinca Institute of Nuclear Sciences, University of Belgrade, Belgrade, Serbia. snezana.tepavcevic@gmail.com
authors.forename: S
authors.initials: S
authors.lastname: Tepavcevic
authors.forename: G
authors.initials: G
authors.lastname: Koricanac
authors.forename: Z
authors.initials: Z
authors.lastname: Zakula
authors.forename: T
authors.initials: T
authors.lastname: Milosavljevic
authors.forename: M
authors.initials: M
authors.lastname: Stojiljkovic
authors.forename: E R
authors.initials: ER
authors.lastname: Isenovic
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D018955:CD36 Antigens / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D004958:Estradiol / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D051272:Glucose Transporter Type 1 / Q000378:metabolism; D051275:Glucose Transporter Type 4 / Q000378:metabolism; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D026901:Membrane Transport Proteins / Q000378:metabolism*; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D001786:Blood Glucose; D018955:CD36 Antigens; D005230:Fatty Acids, Nonesterified; D051272:Glucose Transporter Type 1; D051275:Glucose Transporter Type 4; D007328:Insulin; D026901:Membrane Transport Proteins; C495679:Slc2a1 protein, rat; C495694:Slc2a4 protein, rat; D004958:Estradiol